Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Sanger Sequencing

Sanger Sequencing

DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...

Comparing Copy Number Variations and SNPs

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

Next-generation Sequencing

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bayesian Population-Based Prevalence Estimation of <i>KCNV2</i>-Associated Retinopathy: A Comparative Analysis of Disease-Associated Variant Frequencies in Russian and Global Populations.

International journal of molecular sciences·2026

Same author

The Role of Apoptosis and Ferroptosis in Primary Mitochondrial Diseases: Mechanisms and Pathogenesis.

International journal of molecular sciences·2026

Same author

The Sphingolipid Balance and Endothelial Dysfunction in Lysosomal Storage Diseases: Shared Mechanisms in Gaucher, Niemann-Pick and Fabry Disease.

International journal of molecular sciences·2026

Same author

Elongationless start-stop elements are stress-resilient translation gates that are more repressive than uTranslons.

Nucleic acids research·2026

Same author

Analysis of diagnostic pitfalls in 125 genetically confirmed cases of distal myopathies.

Journal of neuromuscular diseases·2026

Same author

Upregulation of adenylyl cyclase 1 is crucial for osteogenic and adipogenic differentiation of MSCs.

Cells & development·2026

Search research articles

Related Experiment Video

Updated: May 30, 2025

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

Sanger validation of WGS variants.

Arina Kopernik¹, Mariia Sayganova¹, Gaukhar Zobkova²

¹Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Moscow, Russia, 125315.

Scientific Reports

|January 29, 2025

Summary

Next-generation sequencing (NGS) enables millions of variant analyses. This study establishes quality thresholds for whole genome sequencing (WGS) variants, significantly reducing the need for Sanger validation.

More Related Videos

Validating Whole Genome Nanopore Sequencing, using Usutu Virus as an Example

Validating Whole Genome Nanopore Sequencing, using Usutu Virus as an Example

Published on: March 11, 2020

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Related Experiment Videos

Last Updated: May 30, 2025

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

Validating Whole Genome Nanopore Sequencing, using Usutu Virus as an Example

Validating Whole Genome Nanopore Sequencing, using Usutu Virus as an Example

Published on: March 11, 2020

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Area of Science:

Genomics
Molecular Biology
Bioinformatics

Background:

Next-generation sequencing (NGS) allows simultaneous analysis of millions of genetic variants.
Orthogonal validation of variants identified by NGS is often required, despite quality improvements.
Defining quality thresholds for high-confidence variants could eliminate the need for validation.

Purpose of the Study:

To analyze the concordance between whole genome sequencing (WGS) variants and Sanger validation.
To establish quality thresholds for filtering high-quality variants from WGS data.
To reduce the number of variants requiring orthogonal validation.

Main Methods:

Analysis of 1756 variants from whole genome sequencing (WGS).
Comparison of WGS variants with gold-standard Sanger sequencing validation.
Development of caller-agnostic (DP, AF) and caller-dependent (QUAL) quality thresholds.

Main Results:

Established concordance rates for WGS variants validated by Sanger sequencing.
Developed specific thresholds for high-quality variant filtering.
Caller-agnostic thresholds reduced validation needs to 4.8% of variants.
Caller-dependent thresholds reduced validation needs to 1.2% of variants.

Conclusions:

Quality thresholds can significantly decrease the number of WGS variants requiring validation.
The study provides data-driven thresholds for reliable variant filtering in WGS.
This approach enhances the efficiency of genomic variant analysis.